Back to Journals » OncoTargets and Therapy » Volume 11

CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis

Total article views   HTML views PDF downloads Totals
6,917 Dovepress* 6,389+ 975 7,364
PubMed Central* 528 142 670
Totals 6,917 1,117 8,034
*Since 27 February 2018

View citations on PubMed Central and Google Scholar